Barclays stock price forecast: technicals signal consolidation as BARC slips 0.39% to £469.75

Traders Union
All News
Financial News
Barclays slips 0.39% to GBX 469.75

Highlights

Barclays has repurchased and cancelled over 47 million ordinary shares since October 23, 2025, at an average price of 445.5510p, advancing its £10 billion capital return target for 2024–2026.
The bank released a Base Prospectus Supplement approved by the FCA and a Form 8.3 regulatory filing on holdings in Spire Healthcare Group PLC.
Barclays plans to invest approximately £45 billion in increased lending and £4.4 billion in direct investment in its UK operations over the next three years.

Share buybacks and record investments drive upbeat capital return outlook

Barclays continues its substantial capital return program, having repurchased and cancelled over 47 million ordinary shares since October 23, 2025, at an average price of 445.5510p as part of its goal to return at least £10 billion to shareholders between 2024 and 2026. The bank also recently released regulatory updates, including a Base Prospectus Supplement approved by the FCA and a Form 8.3 filing on holdings in Spire Healthcare Group PLC. Additionally, Barclays announced plans to invest approximately £45 billion in increased lending and £4.4 billion in direct investment in its UK operations over the next three years.

Overbought signals emerge as buyers maintain control amid mild selling

Momentum indicators on the daily chart remain positive, with the MACD and ADX showing buyers in control. However, overbought signals are apparent: the daily RSI is elevated at 74.22, Stochastic RSI and CCI are both in overbought territory, and BBP readings signal continued buyer dominance. The Awesome Oscillator also supports the prevailing bullish trend. Despite the overall solid momentum, today's session shows mild profit-taking, with the price down 1.85 to GBX 469.75, slipping 0.39% from the previous close after opening with no significant gap. Price is currently positioned near the lower end of today’s range, and volatility has been moderate, with a slight downward drift following some selling pressure after the open.

Bullish extension likely if uptrend persists amid volatile outlook

Looking ahead to the next five trading days, the expected price range is GBX 460 to GBX 485. Based on weekly and daily momentum including RSI, ADX, MACD, and moving averages, there is a very high probability (more than 80%) of further gains, making a decline much less likely in the short term. The baseline scenario anticipates a sideways corridor within this volatility band, supported by firm trend indicators. The bullish case envisions a break above GBX 475 — 485, extending the uptrend if momentum persists, while a bearish scenario would see breakdowns below GBX 460 and a potential test of the Ichimoku support near GBX 431 if profit-taking accelerates or momentum indicators reverse.

Viktoras Karapetjanc, analyst at Traders Union, sees Barclays PLC supported by robust fundamentals and ongoing capital return initiatives. He believes strong momentum is reinforced by the bank’s active buyback program and recent regulatory progress. Capital investment plans further boost investor confidence and sentiment around the stock. The constructive price action is matched by technical overbought signals, and short-term volatility may persist. "Risk remains tilted to the upside, with GBX 475 as the next pivot for bullish continuation if sentiment and fundamentals hold steady."

Previously it was reported that Barclays PLC continues to display strong bullish momentum, with the price trading well above key moving averages and trend indicators like MACD and ADX confirming robust buyer strength. However, overbought signals from RSI and other oscillators, alongside mild intraday weakness, suggest limited short-term upside and a likelihood of sideways consolidation above dynamic support near the Ichimoku Kijun.

Source of Data: BARC Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.